Review article: managing the dyspeptic patient - an interactive discussion

被引:3
作者
Malfertheiner, P
Stanghellini, V
Galmiche, JP
Jones, RH
机构
[1] Univ Magdeburg, Dept Gastroenterol Hepatol & Infect Dis, D-39120 Magdeburg, Germany
[2] Univ Bologna, I-40126 Bologna, Italy
[3] Univ Hosp CHU, Nantes, France
[4] Guys Kings & St Thomas Sch Med, London, England
关键词
D O I
10.1046/j.1365-2036.2001.00117.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Dyspepsia, a common disorder, can present some difficult clinical dilemmas. Physicians should explore some of the more challenging cases of dyspepsia in a setting that fosters interactive dialogue among colleagues, as was the case at the interactive discussion reported below. A panel of experts presented and discussed three case histories. The audience was able to choose from among several options for diagnosis or treatment and recorded their votes by means of an electronic handset. The first case concerned the relationship between continued non-steroidal antiinflammatory drug (NSAID) use and recurrent upper gastrointestinal (Gl) symptoms without ulcer or Helicobacter pylori infection. The second was a woman with complex upper GI symptoms including heartburn. The last featured a young man with dyspepsia and no alarm symptoms. The first case showed that a standard dose of proton pump inhibitor (PPI) is the best treatment for patients with gastritis who continue to use NSAIDs. The second case revealed that 24-h pH monitoring can be used to establish a relationship between symptoms and reflux episodes. The third case demonstrated that it can be difficult to make a definitive diagnosis based on clinical symptoms. and that patients with endoscopy-negative reflux disease usually respond well to PPI therapy.
引用
收藏
页码:14 / 19
页数:6
相关论文
共 10 条
[1]
Challenges in managing dyspepsia in general practice [J].
Agreus, L ;
Talley, N .
BRITISH MEDICAL JOURNAL, 1997, 315 (7118) :1284-1288
[2]
EMPIRICAL H-2-BLOCKER THERAPY OR PROMPT ENDOSCOPY IN MANAGEMENT OF DYSPEPSIA [J].
BYTZER, P ;
HANSEN, JM ;
DEMUCKADELL, OBS .
LANCET, 1994, 343 (8901) :811-816
[3]
DELANEY BC, 2000, COCHRANE DATABASE SY
[4]
Management of gastro-oesophageal reflux disease in general practice [J].
Deng, J ;
Jones, R ;
Kahrilas, P ;
Talley, NJ .
BRITISH MEDICAL JOURNAL, 2001, 322 (7282) :344-347
[5]
An evaluation of near-patient testing for Helicobacter pylori in general practice [J].
Jones, R ;
Phillips, I ;
Felix, G ;
Tait, C .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (01) :101-105
[6]
Jones R, 1999, INT J CLIN PRACT, V53, P413
[7]
Costs and benefits of a test-and-treat strategy in Helicobacter pylori-infected subjects:: a prospective intervention study in general practice [J].
Joosen, EAM ;
Reininga, JHA ;
Manders, JMW ;
ten Ham, JC ;
de Boer, WA .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (03) :319-325
[8]
Test and treat strategies for Helicobacter pylori in uninvestigated dyspepsia:: A Canadian economic analysis. [J].
Marshall, JK ;
Armstrong, D ;
O'Brien, BJ .
CANADIAN JOURNAL OF GASTROENTEROLOGY, 2000, 14 (05) :379-388
[9]
Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer [J].
McColl, KEL ;
El-Nujumi, A ;
Murray, LS ;
El-Omar, EM ;
Dickson, A ;
Kelman, AW ;
Hilditch, TE .
GUT, 1998, 42 (05) :618-622
[10]
Talley NJ, 1998, ALIMENT PHARM THERAP, V12, P641